Accordingly, with the use of CSC, which is considered a very effective model for investigating drug-resistance, we demonstrate the importance of IL-6 signaling in triggering increased cisplatin efficacy in laryngeal cancer. This evidence concerns the gene IL6 and laryngeal carcinoma.